Are you Dr. Park?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
130 W Kingsbridge Rd 3c32
Bronx, NY 10468Phone+1 718-584-9000Fax+1 718-741-4647
Summary
- Dr. Yeun-Hee Park, MD is an oncologist in Bronx, New York. She is currently licensed to practice medicine in New York, District of Columbia, and Virginia. She is affiliated with James J. Peters Veterans Affairs Medical Center and New York-Presbyterian Hospital.
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2004 - 2005
- MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2003 - 2004
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1999 - 2002
- University of New Mexico School of MedicineClass of 1999
Certifications & Licensure
- DC State Medical License 2003 - Present
- NY State Medical License 2005 - 2026
- VA State Medical License 2003 - 2010
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Publications & Presentations
PubMed
- Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, Mina Meseha, Izak Faiena
Ebiomedicine. 2024-09-01 - Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer.Harshraj Leuva, George Moran, Nader Jamaleddine, Mina Meseha, Mengxi Zhou
Seminars in Oncology. 2024-05-11 - 3 citationsNeutrophil-to-lymphocyte ratio as a predictor of surgical outcomes in head and neck cancer.Derek D Kao, Rocco M Ferrandino, Scott A Roof, Deborah C Marshall, Mohemmed Nazir Khan
Head & Neck. 2023-08-01